Gentian Diagnostics ASA
Develops & manufactures IVD immunoassays for human & veterinary disease diagnostics.
GENT | OL
Overview
Corporate Details
- ISIN(s):
- NO0010748866
- LEI:
- 5967007LIEEXZXHNM861
- Country:
- Norway
- Address:
- Bjørnåsveien 5, 1596 Moss
- Website:
- https://www.gentian.com/
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
Gentian Diagnostics ASA is a global developer and manufacturer of in vitro diagnostic (IVD) reagents. The company specializes in turbidimetric immunoassays designed for major clinical chemistry platforms, aiming to enhance diagnostic efficiency for laboratories. Its product portfolio addresses high-value biomarkers for both human and veterinary medicine, with a focus on kidney disease, cardiac disease, inflammation, and infection. By developing innovative and efficient diagnostic tests, Gentian enables laboratories to reduce costs and deliver faster, more accurate results to support better treatment decisions. The company serves the global market through a network of OEM partners, distributors, and healthcare providers.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2025-10-23 10:15 |
Regulatory News Service
Gentian Diagnostics: Study Confirms the Value of Calprotectin in Early Detectio…
|
English | 102.9 KB | ||
| 2025-10-23 10:15 |
Regulatory News Service
Gentian Diagnostics: Study Confirms the Value of Calprotectin in Early Detectio…
|
English | 3.2 KB | ||
| 2025-10-23 08:00 |
Investor Presentation
Gentian Diagnostics: Third quarter 2025 report - Attachment: GDASA Q3 25 presen…
|
English | 2.1 MB | ||
| 2025-10-23 08:00 |
Quarterly Report
Gentian Diagnostics: Third quarter 2025 report - Attachment: GDASA Interim repo…
|
English | 865.7 KB | ||
| 2025-10-23 08:00 |
Earnings Release
Gentian Diagnostics: Third quarter 2025 report
|
English | 3.2 KB | ||
| 2025-10-16 09:55 |
Report Publication Announcement
Gentian Diagnostics: Invitation to presentation of third quarter results
|
English | 721 bytes | ||
| 2025-09-16 08:11 |
Investor Presentation
Gentian Diagnostics presents at the Pareto Securities Healthcare conference - A…
|
English | 1.3 MB | ||
| 2025-09-16 08:11 |
Report Publication Announcement
Gentian Diagnostics presents at the Pareto Securities Healthcare conference
|
English | 683 bytes | ||
| 2025-07-10 08:00 |
Interim Report
Gentian Diagnostics: Second quarter 2025 report - Attachment: GDASA Interim re…
|
English | 859.1 KB | ||
| 2025-07-10 08:00 |
Investor Presentation
Gentian Diagnostics: Second quarter 2025 report - Attachment: GDASA Q2 25 pres…
|
English | 2.2 MB | ||
| 2025-07-10 08:00 |
Earnings Release
Gentian Diagnostics: Second quarter 2025 report
|
English | 2.7 KB | ||
| 2025-07-03 13:22 |
Report Publication Announcement
Gentian Diagnostics: Invitation to presentation of second quarter results
|
English | 721 bytes | ||
| 2025-06-02 16:34 |
Major Shareholding Notification
Flaggemelding Gentian Diagnostics ASA
|
Norwegian | 495 bytes | ||
| 2025-05-23 09:39 |
Major Shareholding Notification
Disclosure of shareholding
|
English | 986 bytes | ||
| 2025-05-22 08:47 |
Major Shareholding Notification
Disclosure of large shareholding
|
English | 893 bytes |
Automate Your Workflow. Get a real-time feed of all Gentian Diagnostics ASA filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Gentian Diagnostics ASA
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Gentian Diagnostics ASA via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
/other/Diamyd_Medical_AB_publ-logo.png){kind=logo}
